Evidence map›Paper›PMID 28336852›Full record

ArticleNanomaterials (Basel, Switzerland)2017

Amorphous Silica Particles Relevant in Food Industry Influence Cellular Growth and Associated Signaling Pathways in Human Gastric Carcinoma Cells.

Anja Wittig, Helge Gehrke, Giorgia Del Favero, Eva-Maria Fritz, Marco Al-Rawi, Silvia Diabaté, Carsten Weiss, Haider Sami, Manfred Ogris, Doris Marko

Open access · goldAbstract read
In one paragraph

Article in Nanomaterials (Basel, Switzerland), 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
1.9field-weighted citation impact, top 17% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 20 citations in OpenAlex.

  1. Article
  2. Article
  3. Toxicology and Biocompatibility of Nanomaterials.Nanomaterials (Basel, Switzerland) · 2021
    Article
  4. Article
  5. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 2 institutions in 2 countries.

Anja WittigDepartment of Food Chemistry and Toxicology, Faculty of Chemistry, University of Vienna, Waehringer Strasse 38, 1090 Vienna, Austria. anja.wittig@univie.ac.at.
Helge GehrkeDepartment of Food Chemistry and Toxicology, Faculty of Chemistry, University of Vienna, Waehringer Strasse 38, 1090 Vienna, Austria. helge.gehrke@gmx.de.
Giorgia Del FaveroDepartment of Food Chemistry and Toxicology, Faculty of Chemistry, University of Vienna, Waehringer Strasse 38, 1090 Vienna, Austria. giorgia.del.favero@univie.ac.at.
Eva-Maria FritzDepartment of Food Chemistry and Toxicology, Faculty of Chemistry, University of Vienna, Waehringer Strasse 38, 1090 Vienna, Austria. efritz@gmx.at.
Marco Al-RawiInstitute of Toxicology and Genetics (ITG), Karlsruhe Institute of Technology (KIT), Campus Nord, Hermann-von-Helmholtz-Platz 1, 76344 Eggenstein-Leopoldshafen, Germany. marco.al-rawi@web.de.
Silvia DiabatéInstitute of Toxicology and Genetics (ITG), Karlsruhe Institute of Technology (KIT), Campus Nord, Hermann-von-Helmholtz-Platz 1, 76344 Eggenstein-Leopoldshafen, Germany. silvia.diabate@kit.edu.
Carsten WeissInstitute of Toxicology and Genetics (ITG), Karlsruhe Institute of Technology (KIT), Campus Nord, Hermann-von-Helmholtz-Platz 1, 76344 Eggenstein-Leopoldshafen, Germany. carsten.weiss@kit.edu.
Haider SamiMMCT Laboratory of Macromolecular Cancer Therapeutics, Department for Pharmaceutical Chemistry, Faculty Center for Pharmacy, University of Vienna, Althanstraße 14, 1090 Vienna, Austria. haider.sami@univie.ac.at.
Manfred OgrisMMCT Laboratory of Macromolecular Cancer Therapeutics, Department for Pharmaceutical Chemistry, Faculty Center for Pharmacy, University of Vienna, Althanstraße 14, 1090 Vienna, Austria. m.ogris@univie.ac.at.
Doris MarkoDepartment of Food Chemistry and Toxicology, Faculty of Chemistry, University of Vienna, Waehringer Strasse 38, 1090 Vienna, Austria. doris.marko@univie.ac.at.
University of Vienna · ATKarlsruhe Institute of Technology · DE

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Nanostructured silica particles are commonly used in biomedical and biotechnical fields, as well as, in cosmetics and food industry. Thus, their environmental and health impacts are of great interest and effects after oral uptake are only rarely investigated. In the present study, the toxicological effects of commercially available nano-scaled silica with a nominal primary diameter of 12 nm were investigated on the human gastric carcinoma cell line GXF251L. Besides the analysis of cytotoxic and proliferative effects and the comparison with effects of particles with a nominal primary diameter of 200 nm, emphasis was also given to their influence on the cellular epidermal growth factor receptor (EGFR) and mitogen-activated protein kinases (MAPK) signaling pathways-both of them deeply involved in the regulation of cellular processes like cell cycle progression, differentiation or proliferation. The investigated silica nanoparticles (NPs) were found to stimulate cell proliferation as measured by microscopy and the sulforhodamine B assay. In accordance, the nuclear level of the proliferation marker Ki-67 was enhanced in a concentration-dependent manner. At high particle concentrations also necrosis was induced. Finally, silica NPs affected the EGFR and MAPK pathways at various levels dependent on concentration and time. However, classical activation of the EGFR, to be reflected by enhanced levels of phosphorylation, could be excluded as major trigger of the proliferative stimulus. After 45 min of incubation the level of phosphorylated EGFR did not increase, whereas enhanced levels of total EGFR protein were observed. These results indicate interference with the complex homeostasis of the EGFR protein, whereby up to 24 h no impact on the transcription level was detected. In addition, downstream on the level of the MAP kinases ERK1/2 short term incubation appeared to affect total protein levels without clear increase in phosphorylation. Depending on the concentration range, enhanced levels of ERK1/2 phosphorylation were only observed after 24 h of incubation. Taken together, the present study demonstrates the potential of the tested silica particles to enhance the growth of gastric carcinoma cells. Although interference with the EGFR/MAPK cascade is observed, additional mechanisms are likely to be involved in the onset of the proliferative stimulus.

Indexed as

cytotoxicityEGFR and MAPK signalinggastrointestinal tractKi-67proliferationsilica particles

Identifiers

PMID28336852
PMCPMC5295208
OpenAlexW2579845457

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.